Articles

The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis

Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany
Institute for Transfusion Medicine DRK- Blutspendedienst Baden-Württemberg – Hessen, Frankfurt am Main, Germany
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany
Institute of Cardiovascular Regeneration, Center for Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany
Institute of Cardiovascular Regeneration, Center for Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany
Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany
Fred Hutchinson Cancer Research Center, Clinical Research Division, Biostatistics, Seattle, WA, USA
Fred Hutchinson Cancer Research Center, Clinical Research Division, Biostatistics, Seattle, WA, USA
Institute for Hematology and Oncology, Mannheim, Germany
Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
Department of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt am Main, Germany;German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany
Fred Hutchinson Cancer Research Center, Clinical Research Division, Division of Hematology, University of Washington Medical Center, Seattle, WA, USA
Institute for Transfusion Medicine DRK- Blutspendedienst Baden-Württemberg – Hessen, Frankfurt am Main, Germany
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany;German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;Faculty of Medicine, Johann Wolfgang Goethe University, Frankfurt;Frankfurt Cancer Institute, Frankfurt, Germany
Vol. 105 No. 1 (2020): January, 2020 https://doi.org/10.3324/haematol.2018.212365